Chris Lau

Chris Lau

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Why Virgin Galactic Could Keep Falling as Investor Unease Increases

SPCE stock faces selling pressure as revenue bookings may not translate to sales in 2021. Put Virgin Galatic on the future "maybe" list.

7 Tarnished Blue-Chip Stocks to Ditch Now

Not all blue-chip stocks are good to hold forever. These companies are struggling to cut costs and could fall further. Sell them now.

When It Comes to UAL Stock, There’s Nothing to Do but Wait

UAL stock faces plenty of uncertainties in the short-term as passenger traffic keeps dropping. The best thing to do is wait and see.

Palo Alto Networks Stock Could Drop Further

Palo Alto Networks offers important tech solutions, but PANW stock trades at unfavorable valuations while investors shun holding risk.

7 Tech Stocks to Buy For an Interconnected World

As smart devices proliferate around the world, investors looking to profit on the Internet of Things should get in on these stocks to buy.

Southwest Airlines Stock Is Trading at Prices Too Low to Ignore

Yes, the airline industry is facing an uncertain future and sharp revenue loss. But LUV stock is trading at a price that's just too cheap.

Carnival Stock Will Survive and Thrive Even Without a Bailout

Investors expect Carnival to face steep losses ahead, as the coronavirus impacts demand. But CCL will survive and thrive in the long term.

7 Biotech Stocks to Buy That Could Beat the Coronavirus

These biotech stocks are all working on treatments that have the potential to beat the coronavirus. Don't just wait for a cure. Buy them now.

The Pending Mellanox Acquisition Will Sustain Nvidia Stock Here

NVDA stock fell along with the market but it has since rebounded. Its Mellanox acquisition will help it grow for several years.

Chesapeake Energy Stock Is Unlikely to Survive the Downturn

What happens in a bankruptcy? Shareholders in Chesapeake Energy will suffer as CHK stock essentially becomes worthless.